A Telehealth Advance Care Planning Intervention

Last updated: March 28, 2025
Sponsor: University of Rochester
Overall Status: Active - Recruiting

Phase

N/A

Condition

Myelofibrosis

Leukemia

Neoplasms

Treatment

Education Control

Telehealth Serious Illness Care Program

Clinical Study ID

NCT05875805
UOCPC23038
  • Ages > 60
  • All Genders

Study Summary

The objective of this project is to conduct a pilot randomized trial to assess the preliminary efficacy of a telehealth-delivered Serious Illness Care Program on healthcare communication, patient anxiety and distress, as well as completion of advance directives (specifically MOLST and healthcare proxy forms) for older patients with acute myeloid leukemia, myelodysplastic syndrome, and similar myeloid malignancies.

Eligibility Criteria

Inclusion

Inclusion and Exclusion Criteria for Patients

Inclusion criteria:

  • Age ≥60 years

  • A diagnosis of AML, MDS, and similar myeloid malignancies (including but not limitedto MDS/MPN overlap syndrome, myelofibrosis)

  • Being managed in the outpatient settings

  • Able to provide informed consent

  • English-speaking

Exclusion

Exclusion criteria:

  • None

Inclusion and Exclusion Criteria for Caregivers

Inclusion criteria:

  • Age ≥18 years

  • Selected by patient when asked if there is a "family member, partner, friend, orcaregiver with whom you discuss or who can be helpful in health-related matters"

  • Able to provide informed consent

  • English-speaking

Exclusion criteria:

  • None

Inclusion and Exclusion Criteria for Oncology Providers

Inclusion criteria:

  • Oncologists and/or APPs who will be conducting the telehealth-delivered ACP visit

Exclusion criteria:

  • None

Study Design

Total Participants: 207
Treatment Group(s): 2
Primary Treatment: Education Control
Phase:
Study Start date:
May 20, 2024
Estimated Completion Date:
December 31, 2025

Study Description

The Serious Illness Care Program (SICP) is an evidence-based intervention to enhance serious illness conversations between physicians and patients with advanced cancer. It consists of the Serious Illness Conversation Guide as well as training and system-level support for clinicians to conduct serious illness conversations. The investigators have previously adapted the SICP to be delivered via telehealth for older adults with myeloid malignancies. In this study, they will conduct a pilot randomized trial to assess the preliminary efficacy of a telehealth-delivered Serious Illness Care Program compared to an education control.

Connect with a study center

  • University of Rochester

    Rochester, New York 14642
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.